Sign In
Buy SNY
$43.98
-0.680 (-1.52%)
At Close: Jul 20, 2026
Regeneron, Sanofi Blockbuster Dupixent Scores FDA Nod For Rare Sinus Condition
01:47pm, Tuesday, 24'th Feb 2026
• Regeneron Pharmaceuticals stock is facing resistance. Why are REGN shares declining?
Press Release: Sanofi and Regeneron's Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis
09:30am, Tuesday, 24'th Feb 2026
Sanofi and Regeneron's Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis Approval in adults and children aged 6 years and older supported by phase 3 study d
Texas sues Sanofi for allegedly 'bribing' providers to boost drug prescriptions
06:06pm, Thursday, 19'th Feb 2026
Texas Attorney General Ken Paxton on Thursday sued Sanofi for allegedly "bribing" providers to prescribe its medications over alternatives.
Filing of the 2025 U.S. Form 20-F and French “Document d'Enregistrement Universel” containing the Annual Financial Report
Sanofi announces leadership evolution in Specialty Care Business Unit
08:30am, Tuesday, 17'th Feb 2026
CAMBRIDGE, Mass., Feb. 17, 2026 /PRNewswire/ -- Sanofi today announced the appointment of Manuela Buxo as Head of Specialty Care, effective March 1, 2026.
Teva Pharmaceutical's New Study Shows Lasting Relief For Inflammatory Bowel Disease Patients
07:04am, Tuesday, 17'th Feb 2026
Teva and Sanofi SA (NASDAQ: SNY) released positive results on Tuesday from the RELIEVE UCCD long-term extension study of duvakitug, an investigational human monoclonal antibody targeting TL1A.
Teva will hold an investor call and live webcast today, Tuesday, February 17, 2026, at 8:00 a.m. ET to discuss these data.
Sanofi and Teva's duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn's disease
Drugmaker Sanofi to expand India GCC, increase workforce to over 4,500 employees
07:07am, Monday, 16'th Feb 2026
French drugmaker Sanofi said on Monday it will expand its global capability centre (GCC) in the southern Indian city of Hyderabad, and increase its workforce to more than 4,500 employees.
Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season
01:00am, Monday, 16'th Feb 2026
Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season First study showing that infants immunized against RSV in their first season had fewer RSV
Atria Investments Inc Has $5.54 Million Stock Holdings in Sanofi $SNY
05:46am, Sunday, 15'th Feb 2026
Atria Investments Inc trimmed its position in Sanofi (NASDAQ: SNY) by 12.2% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 117,300 shares of the company
Assetmark Inc. Increases Stake in Sanofi $SNY
05:02am, Sunday, 15'th Feb 2026
Assetmark Inc. boosted its stake in shares of Sanofi (NASDAQ: SNY) by 25.0% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission
Caprock Group LLC Makes New Investment in Sanofi $SNY
04:12am, Sunday, 15'th Feb 2026
Caprock Group LLC acquired a new stake in shares of Sanofi (NASDAQ: SNY) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC).
Weekend Morning Brew: AI Jitters, Novo--Hims Clash, McDonald's Beat
07:37am, Saturday, 14'th Feb 2026
Weekly Market HighlightsWeekly breadth was slightly negative with 4,703 advancers versus 4,832 decliners, even as 963 stocks gained more than 10% and 1,151 fel
SNY Stock Falls After Board Suddenly Makes Leadership Change
01:55pm, Friday, 13'th Feb 2026
Sanofi stock slides 4.5% after it decides not to renew CEO Paul Hudson's mandate and names Belen Garijo as successor amid investor skepticism.
